• Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-IGH (PubMed=8650231).
  

PubMed=3034807; DOI=10.1002/ijc.2910390622
Ohno H., Fukuhara S., Takahashi R., Mihara K.-i., Sugiyama T., Doi S., Uchino H., Toyoshima K.
c-yes and bcl-2 genes located on 18q21.3 in a follicular lymphoma cell line carrying a t(14;18) chromosomal translocation.
Int. J. Cancer 39:785-788(1987)

PubMed=2852183; DOI=10.1111/j.1349-7006.1988.tb01544.x; PMCID=PMC5917646
Kamesaki H., Miwa H., Ohno Y., Miyanishi S., Yamabe H., Doi S., Arita Y., Ohno H., Tatsumi E., Nishikori M., Fukuhara S., Hatanaka M., Uchino H.
A novel B cell line established from Ki-1-positive diffuse large cell lymphoma.
Jpn. J. Cancer Res. 79:1193-1200(1988)

PubMed=8650231; DOI=10.1073/pnas.93.12.6129; PMCID=PMC39201
Busslinger M., Klix N., Pfeffer P., Graninger P.G., Kozmik Z.
Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Proc. Natl. Acad. Sci. U.S.A. 93:6129-6134(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=19358282; DOI=10.1002/ijc.24351
Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M., Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.
Int. J. Cancer 125:212-221(2009)